Pfizer to acquire Neksium brand from AstraZeneca for Rs 75 cr Industry-The Economic Times — May 31, 2017 comments off “The company is well placed to grow the Neksium brand further through its existing reach, coverage and equity in the gastrointestinal therapy area.”
“The company is well placed to grow the Neksium brand further through its existing reach, coverage and equity in the gastrointestinal therapy area.”